psd-502 has been researched along with Gagging* in 2 studies
1 trial(s) available for psd-502 and Gagging
Article | Year |
---|---|
Anesthetic effect of EMLA occluded with Orahesive oral bandages on oral mucosa. A placebo-controlled study.
The efficiency of a topical anesthetic occluded with Orahesive Oral Bandage was investigated. Experimental pain was provoked by needle insertions into two palatal test areas in 20 healthy subjects. Pain, estimated on a 100-mm visual analogue scale (VAS), decreased significantly from 23.5 mm to 10.5 mm at the greater palatine foramen and from 51.5 mm to 35.0 mm at the incisive foramen after application of a eutectic mixture of local anesthetics (EMLA). No significant change in pain perception was obtained after placebo application. The EMLA cream and the Orahesive Oral Bandages were well accepted by the subjects, as only two out of 20 subjects experienced slight gagging reflexes and only three considered the taste unpleasant. No other adverse reactions were observed. Occlusion of topical anesthetics seems to be a useful technique for achieving superficial mucosal anesthesia. Topics: Administration, Topical; Adult; Anesthesia, Dental; Anesthetics, Local; Double-Blind Method; Drug Combinations; Female; Gagging; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Mouth Mucosa; Occlusive Dressings; Pain Measurement; Palate; Patient Satisfaction; Prilocaine | 1992 |
1 other study(ies) available for psd-502 and Gagging
Article | Year |
---|---|
The efficacy and safety of EMLA cream for awake fiberoptic endotracheal intubation.
EMLA Cream (EC; Astra, Westborough, MA) has been widely used as a local anesthetic. Limited safety information is available with respect to the application of EC to the oral mucous membranes. The purpose of this pilot study was to evaluate the efficacy and safety of EC when applied to oral mucosa for fiberoptic intubation. Twenty ASA physical status I-IV patients (11 women and 9 men), 28-57 yr old, who were scheduled for awake, fiberoptic, intubation participated in this open-label study. A total of 4 g of EC was used for 5 min until the patient showed no evidence of a gag reflex (this was evaluated clinically by the patient's acceptance of the William's airway and considered the endpoint for assessing adequate topicalization of the oropharynx). The measured peak plasma concentration of lidocaine or prilocaine did not reach toxic levels in any patient. Methemoglobin levels did not exceed normal values (1.5%) in any patient, and there was no relationship between methemoglobin levels and patient weight, amount of EC used, measured peak plasma concentration, or times to measured peak concentrations of prilocaine or lidocaine. We conclude that EC provided satisfactory topical anesthesia allowing for successful oral fiberoptic intubation in all patients and should be considered a safe alternative for anesthetizing the airway of patients requiring awake oral fiberoptic intubation. Topics: Adult; Anesthetics, Combined; Anesthetics, Local; Body Weight; Female; Fiber Optic Technology; Gagging; Half-Life; Humans; Intubation, Intratracheal; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Methemoglobin; Middle Aged; Mouth Mucosa; Ointments; Oropharynx; Pilot Projects; Prilocaine; Safety; Time Factors; Treatment Outcome; Wakefulness | 2000 |